Comparison of the methods for tumor response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
Authors:
- Ji Hoon KimJKJi Hoon Kim
- Eileen L. YoonEYEileen L. Yoon
- Hyun Jung LeeHLHyun Jung Lee
- Soon Jae LeeSLSoon Jae Lee
- Sang Jun SuhSSSang Jun Suh
- Beom Jae LeeBLBeom Jae Lee
- Yeon Seok SeoYSYeon Seok Seo
- Hyung Joon YimHYHyung Joon Yim
- Tae-Seok SeoTSTae-Seok Seo
- Chang Hee LeeCLChang Hee Lee
- Jong Eun YeonJYJong Eun Yeon
- 1 June 2013
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 58 (6) , 1181-1187
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Modified RECIST (mRECIST) Assessment for Hepatocellular CarcinomaSeminars in Liver Disease, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Primary liver cancer: Worldwide incidence and trendsGastroenterology, 2004
- Chemoembolization for hepatocellular carcinomaGastroenterology, 2004
- End Points and United States Food and Drug Administration Approval of Oncology DrugsJournal of Clinical Oncology, 2003
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 1999
- Reporting results of cancer treatmentCancer, 1981